Clinical Trial Update: Effect of a Multidomain Intervention Plus Turmeric on the Prevention of Cognitive Decline in People Over 55 Years of Age With Insulin Resistance. [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 trial sponsored by Instituto Mexicano del Seguro Social is testing whether a multidomain lifestyle intervention plus turmeric (curcumin) can prevent…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cognitive Decline
• Insulin Resistance
• Subjective Cognitive Impairment

Drugs mentioned

• Turmeric/Curcumin (Curcumin)

Snippet

Sponsor: Instituto Mexicano del Seguro Social | Conditions: Cognitive Decline, Subjective Cognitive Impairment | Phase 2, Phase 3 | Status: ACTIVE_NOT_RECRUITING